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Role of Neurotropins in Rat Embryonic Testis Morphogenesis (Cord Formation)1
Elena Levine,3,4 Andrea S. Cupp,4 and Michael K. Skinner2
Center for Reproductive Biology, Department of Genetics and Cell Biology, Washington State University, Pullman,
Washington 99164-4231
ABSTRACT
The process of seminiferous cord formation is the first mor-
phological event that differentiates a testis from an ovary and
indicates male sex determination. Cord formation occurs by em-
bryonic Day 14 (Day 0 5 plug date; E14) in the rat. A series of
experiments were conducted to determine if neurotropins and
their receptors are important for the process of rat embryonic
cord formation. The expression of low affinity neurotropin re-
ceptor (p75/LNGFR) was determined by immunohistochemistry
on sections of both testis and ovary from E13 through birth (Day
0, P0) with an antibody to p75/LNGFR. The staining for p75/
LNGFR was present in the mesonephros of E13 gonads and in a
sex-specific manner appeared around developing cords at E14
in the embryonic testis. At birth, staining for p75/LNGFR was
localized to a single layer of cells (i.e., peritubular cells) that
surrounded the seminiferous cords. The genes for both neuro-
tropin 3 (NT3) and for corresponding high affinity neurotropin
trkC receptor were found to be expressed in the E14 rat testis,
as well as other neurotropins and receptors. Immunocytochem-
ical analysis of E14 rat testis demonstrated that NT3 was local-
ized to the Sertoli cells and trkC was present in individual cells
of the interstitium at E16 and in selected preperitubular cells at
E18. Previously, the peritubular cells adjacent to the cords were
demonstrated to be derived from migrating mesonephros cells
around the time of cord formation. To determine if neurotropins
were involved in cord formation, the actions of neurotropins
were inhibited. A high affinity neurotropin receptor (trk)-specif-
ic kinase inhibitor, K252a, was used to treat organ cultures of
testes from E13 rats prior to cord formation. Treatment of E13
testis organ cultures with K252a completely inhibited cord for-
mation. K252a-treated organ cultures of E14 testis that con-
tained cords did not alter cord morphology. A second experi-
ment to inhibit neurotropin actions utilized a specific antagonist
trk-IgG chimeric fusion protein and E13 testis organ cultures.
The trk-IgG molecules dimerize with endogenous trk receptors
and inhibit receptor signaling and activation of ligand function.
Forty percent of E13 testis organ cultures treated with trkC-IgG
had significantly reduced cord formation. TrkA-IgG had no ef-
fect on initiation of cords; however, in fifty percent of the treat-
ed organs, a ‘‘swollen’’ appearance of the cord structures was
observed. Experiments using trkB-IgG chimeric protein on E13
organ cultures had no effect on cord formation or cord mor-
phology. The testes from trkC and NT3 knockout mice were ex-
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amined to determine if there were any morphological differenc-
es in the testis. NT3 knockouts appeared to have normal cord
morphology in E15 and E17 testis. TrkC knockout mice also had
normal cord morphology in E14 and P0 testis. Both NT3 and
trkC knockout-mice testis had less interstitial area than wild-
type controls. In addition, the trkC knockout mice have an in-
creased number of cells expressing p75LNGFR within the cords
when compared to controls or NT3 knockout mice. Combined
observations suggest compensation between the different neu-
rotropin ligands, receptors, and/or possibly different growth fac-
tors for this critical biological process. In summary, results sug-
gest a novel nonneuronal role for neurotropins in the process of
cord formation during embryonic rat testis development. The
hypothesis developed is that neurotropins are involved in the
progression of male sex differentiation and are critical for the
induction of embryonic testis cord formation.
INTRODUCTION
A critical event in mammalian male sex determination
is the development of the testis. The differentiation of the
indifferent gonad into a testis is required for male sex de-
termination. The process of cord formation is the critical
morphogenetic event in embryonic testis development.
Identification of specific factors involved in the induction
of cord formation is necessary for an understanding of how
genetic sex, derived in part through SRY and SOX expres-
sion [1, 2], is translated into testis differentiation. Little is
known about the specific factors involved in testis morpho-
genesis. Fibroblast growth factor has been suggested to be
involved in testis development [3]. Recently, analysis of
transforming growth factor b2 expression has suggested
that it may play a role in the embryonic testis [4]. The
functions of these factors remain to be examined. Further
elucidation of such factors is needed to provide insight into
male sex differentiation and the embryonic testis morpho-
genic process.
The mammalian testis develops from the genital ridge
along the medial surface of the mesonephros. Initially there
is no sex-specific differentiation of the gonad, and it is re-
ferred to as indifferent or bipotential. The first sign of male
development is the differentiation of Sertoli cells, which
then aggregate with germ cells and undergo a transition
from mesenchyme to epithelium to form cords [5–7]. There
is no apparent structure in the ovary at this time [8]. The
testis cords remain solid until the lumen forms at puberty
to convert them into tubules. The seminiferous tubules are
the site of spermatogenesis, and there spermatogonia de-
velop into spermatozoa in close interaction with the Sertoli
cells that help form the tubule [9–12]. Surrounding the Ser-
toli cells is a layer of peritubular myoid cells that are re-
sponsible for contraction of the tubule [13–16]. In the in-
terstitial space between the tubules are Leydig cells, which
are responsible for testosterone production and for stromal
fibroblasts, vascular and lymphatic endothelial cells, and
macrophages [17–19].
Organ culture of embryonic testis has revealed a require-
ment for the mesonephros in testis cord formation. Labeled
133NEUROTROPINS AND TESTIS DEVELOPMENT
cells from the mesonephros migrate into the testis during the
culture period and become peritubular, endothelial, and in-
terstitial cells but not Sertoli, Leydig, or germ cells [20,21].
These observations suggest that the migration of cells from
the mesonephros may be critical for cord formation by Ser-
toli cells. Given the close association between Sertoli and
peritubular cells, it appears likely that the pre-peritubular
cells may be involved in cord formation. Hind limb buds
can substitute for the mesonephros in allowing cord forma-
tion in organ culture of embryonic testis. In these cocultures,
hind limb stromal cells migrate into the testis and are re-
quired for cord formation [22]. This implies that the embry-
onic testis may induce the migration of mesenchymal cells.
The fate of the hind limb cells after migration has not been
determined, so it is not known whether they contribute to a
particular cell lineage such as peritubular cells. More re-
cently, an organ culture system was used with the meso-
nephros separated from the testis by an embryonic ovary
[23]. Observations confirmed a requirement for mesonephros
cells to migrate into the testis through the ovary and suggest
the potential presence of a chemotactic factor in the differ-
entiating testis.
The neurotropins are a family of growth factors that are
involved in tissue morphogenesis. The neurotropin family
includes nerve growth factor (NGF), neurotropin 3 (NT3),
neurotropin 4/5 (NT-4/5), and brain-derived neurotrophic
factor (BDNF) [24]. The factors interact with the high af-
finity specific receptors trkA (for NGF), trkC (for NT3),
and trkB (for NT-4/5 and BDNF), and the common low
affinity receptor p75/LNGFR [25–28]. The trk receptors ap-
pear to be capable of mediating most of the identified re-
sponses to neurotropins including neurite outgrowth, neu-
ronal survival, and proliferation of several different cells
[29,30]. p75/LNGFR can modulate the response of the trks
to the neurotropins [26]. In addition p75/LNGFR can signal
independently of the trk receptors using pathways involving
sphingomyelin hydrolysis to generate the second messenger
ceramide [31,32].
Neurotropins are critical in mediating the differentiation,
migration, proliferation, and survival of neurons in the de-
veloping brain and peripheral nervous system [33–37]. In
addition, there is accumulating evidence for nonneuronal
roles of the neurotropins, particularly in mesenchymal-ep-
ithelial interactions [38–45]. The neurotropins have been
implicated in mediating local cell-cell interactions during
morphogenesis in several tissues including the dermatome,
tooth, kidney, and ovary [38–41]. Neurotropins have the
potential to mediate similar processes in the embryonic tes-
tis.
Neurotropins are expressed in the postnatal testis where
they appear to be involved in interactions between Sertoli
and germ cells during spermatogenesis [46–49]. Less is
known about their expression and possible function in the
embryonic testis. The p75/LNGFR has been shown to be
expressed by the mesenchyme surrounding testis cords
[44,50]. This expression suggests that the neurotropins may
be involved in testis development. The objective of the cur-
rent study was to determine if neurotropins are necessary
for morphological sex differentiation (i.e., cord formation).
MATERIALS AND METHODS
Organ Cultures
Timed pregnant Sprague-Dawley rats were obtained
from Charles River (Wilmington, MA). Plug date was con-
sidered to be Day 0. For embryonic Day 13 (E13) dissec-
tions, gonads were dissected out with the mesonephros; for
later-stage dissections, testes alone were dissected. The or-
gans were cultured in drops of medium on Millicell CM
filters (Millipore, Bedford, MA) floating on the surface of
0.4–1 ml of CMRL 1066 media (Gibco BRL, Gaithersburg,
MD) supplemented with penicillin-streptomycin, insulin
(10 mg/ml), and transferrin (10 mg/ml). Antibodies and fac-
tors were added directly to the culture medium. The me-
dium was changed every 1 or 2 days. E13 gonad 1 me-
sonephros cultures were typically kept for 3 days, by which
point cords are well developed. E14 testis cultures were
typically kept for 4 days.
Genomic DNA Isolation and Polymerase Chain Reaction
(PCR) for SRY
To determine the sex of E13 gonads, PCR for SRY was
performed. Embryonic tails were collected to make geno-
mic DNA by standard procedures. Briefly, the tissue was
homogenized through a 25-gauge needle in digestion buffer
(100 mM NaCl, 10 mM Tris pH 8, 25 mM EDTA, 0.5%
SDS), and digested with proteinase K (0.15 mg/ml) for at
least 4 h at 608C. The samples were then extracted twice
with an equal volume of phenol:chloroform:isoamyl alco-
hol (25:24:1), and once with chloroform:isoamyl alcohol.
The DNA was then precipitated by adding 1/10 volume 7.5
M NH4Ac and 3 volumes cold ethanol, and incubating at
2808C for an hour before centrifugation at 48C for 30 min.
Pellets were dried and resuspended in 10 ml dH2O. PCR
was performed using 1 ml of genomic DNA with primers
to SRY. The sequences of the SRY primers are: 59
C G G G A T C C A T G T C A A G C G C C C C A T G -
AATGCATTTATG 39 and 59 GCGGAATTCACTTTAG-
CCCTCCGATGAGGCTGATAT 39. PCR was performed
using an annealing temperature of 558C for 30 cycles to
yield a product of 240 base pairs (bp).
RNA Isolation and Reverse Transcription (RT)-PCR
RNA for RT-PCR was obtained by freezing samples on
dry ice and then using the TRI reagent (Sigma, St. Louis,
MO) for RNA isolation. RT was performed using MMLV-
RT under standard conditions [51]. RT-PCR was per-
formed at 608C annealing temperature for 30 cycles. All
RT-PCR reactions were conducted three times on the same
RNA preparation, and three different RNA preparations
were used for this experiment. A 39 RT reaction was used,
and the primers spanned an intron. The primer sequences
are as follows (PCR product size in parentheses): trkA
59GACGTGCTGGGCAGAGAA39 and 59CTTCCGC-
ATTTGTTGAGCA39 (520 bp); trkB 59GAGCATCTCTC-
GGTCTATGC39 and 59GGTCATCCCAATGATGAC-
AGC39 (230 bp); trkC 59CATGGTTCCA-
GCTCTCTAACACAG39 and 59ACCAGTCACCAC-
TAGCCAAGAATG39 (223 bp); NGF
59CTTCAACAGGACTCACAGGA39 and 59TCTCT-
ACAGGATTTGGGGCT39 (224 bp); NT3 59ATGCA-
GAGCATAAGAGTCAC39 and 59GCCTACGAGTTT-
GTTGTTTTC39 (294 bp); BDNF 59GAAAGTCCCGG-
TATCAAAAG39 and 59CCAGCCAATTCTCTTTTTGC39
(181 bp); NT4/5 59CTGCGTCAGTACTTCTTCG39 and
59ACGCCCGCACATAGGACTG39 (145 bp). Primers for
the constitutively expressed gene cyclophilin were used to
confirm the integrity of the RNA and efficiency of the
PCR reaction as previously described [51]. The identity
of all PCR products were confirmed using restriction di-
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FIG. 1. Immunohistochemistry for p75/
LNGFR in the developing urogenital ridge.
A) E13 ovary 1 mesonephros; B) E13 testis
1 mesonephros; C) E14 ovary 1 meso-
nephros; D) E14 testis 1 mesonephros; E)
E16 ovary 1 mesonephros; F) E16 testis 1
mesonephros. Ovary (O), testis (T), and
mesonephros (M) are labeled. G) 0 day
testis (P0). S, Sertoli; G, germ cell; P, peri-
tubular; I, interstitial cell. Cells positive for
p75/LNGFR are brown, while negative
cells are blue/purple. 3200 except G,
3400 (published at 80%). Representative
of at least three experiments.
gest analysis, and PCR products were subcloned and se-
quenced.
Embedding, Histology, and Immunohistochemistry
Tissues were fixed in Histochoice (Amresco, Solon, OH)
and embedded in paraffin or in JB4 as previously described
[52,53]. Sections were stained with hematoxylin and eosin
(paraffin sections) or with toluidine blue (JB4 sections) as
previously described [52,53]. Immunocytochemistry for
p75/LNGFR was performed as previously described
[52,53]. Briefly, 7-mm sections were deparaffinized and re-
hydrated, permeabilized in 0.1% Triton X-100, quenched in
20% methanol/3% hydrogen peroxide, and blocked in 2.5%
BSA/10% serum for several hours at room temperature be-
fore incubation with primary antibody anti-p75 (REX) (rab-
bit anti-rat) (generously provided by Lou Reichardt, Uni-
versity of California, San Francisco) at 1:4000 dilution
overnight at 48C. Secondary antibody (biotinylated donkey
anti-rabbit from Amersham) was detected using the Vec-
tastain kit (Vector Laboratories, Burlingame, CA) and dia-
minobenzadine (DAB). Slides were counterstained lightly
with hematoxylin to visualize the tissue. Immunohisto-
chemistry for NT3 and trkC was performed as described
previously according to standard procedures [52,53]. Brief-
ly 3- to 7-mm sections were deparaffinized and rehydrated,
microwaved (10 min on high), and blocked in 10% goat
serum for one hour at room temperature. The NT3 primary
antibody was an anti-NT3 peptide antibody (Santa Cruz
Biotechnology [SCB], Santa Cruz, CA) raised against ami-
no acids 139–158 of human NT3 (which is identical to
mouse). The trkC primary antibody was an anti-trkC pep-
tide antibody (SCB) raised against amino acids 798–812 of
porcine trkC (identical to corresponding sequences in rat
and mouse). The NT3 antibody was diluted 1:1000 in 10%
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FIG. 2. Expression of trk receptors and neurotropin ligands by RT-PCR
in E14 testis. The lanes are labeled as follows: 1, molecular weight stan-
dards; 2, trkA; 3, trkB; 4, trkC; 5, NGF; 6, NT3; 7, BDNF; 8, NT4/5.
The sizes of the PCR products are as follows: trkA 520 bp, trkB 230 bp,
trkC 223 bp, NGF 224 bp, NT3 294 bp, BDNF 181 bp, and NT4/5 145
bp. Product identity was confirmed with restriction analysis and se-
quencing. Representative of at least 3 experiments for each.
goat serum. The trkC antibody was diluted 1:600 in 10%
goat serum. The biotinylated goat anti-rabbit secondary an-
tibody (Vector Laboratories) was diluted 1:300. As a neg-
ative control, serial sections were put through the same pro-
cedure without any primary antibody.
Materials
The antibody against p75/LNGFR (anti-p75 rat [REX])
was generously provided by Lou Reichardt, and sections
from NT3 knockout mice were generously provided by Is-
abel Farinas and Lou Reichardt (UCSF, San Francisco, CA).
The trkC knockout mouse testes were provided by Dr. Lino
Tessarollo, NCI, Frederick Cancer Center, Rockville, MD.
The trk-IgG chimeras were generously provided by Rege-
neron (Tarrytown, NY); the trk-IgG chimera proteins have
cross-reactivity on both human and rat tissue. K252a and
calphostin C were obtained from Calbiochem (La Jolla,
CA). Images of whole organs were obtained using a Lu-
mina digital scanning camera (Leaf Systems, Southbor-
ough, MA). NT3 and trkC primary antibodies were ob-
tained from Santa Cruz Biotechnology.
RESULTS
Expression of p75/LNGFR Protein by Immunohisto-
chemistry in the Developing Rat Urogenital Ridge
Previous experiments have demonstrated the presence of
p75/LNGFR mRNA and protein in the embryonic rat testis
[44,50]. Expression was confined to the mesenchyme sur-
rounding the developing testis cords. At later ages, the p75/
LNGFR protein expression became restricted to the peri-
tubular cell layer surrounding the cords [50]. In the current
study, the expression of p75/LNGFR was investigated by
immunohistochemistry in more detail around the critical
period of cord formation. Expression was examined before
the formation of cords (E13) as well as after (E14). Ex-
pression was also examined in female gonads and in the
entire urogenital ridge including the mesonephros.
Expression was first examined in gonads and mesoneph-
ros at E13, just before cord formation, when the testis and
ovary are indistinguishable (Fig. 1, A and B). At this stage,
expression of p75/LNGFR was detectable only in the me-
sonephros in both the male and female. The expression was
particularly high in the region of the mesonephros adjoining
the gonad. After cords formed at E14, the p75/LNGFR was
found in the testis in the mesenchyme surrounding the
cords. There was no p75/LNGFR protein expressed in the
ovary at this stage (Fig. 1, C and D). Later in embryonic
development there was slight staining in the ovary and ex-
tensive staining throughout the testis interstitium (Fig. 1, E
and F). Expression in P0 testis was performed to confirm
the fate of p75/LNGFR positive cells, and, as expected, the
expression was mostly peritubular (Fig. 1G). This data re-
vealed a sex-specific pattern of p75/LNGFR expression at
the time of initiation of the male sexual differentiation path-
way.
Expression of trk Receptors and Neurotropin Ligands
The observation that the common receptor p75/LNGFR
is present in such an interesting temporal and sex-specific
pattern suggests that some of the neurotropin ligands and
high affinity trk receptors may be present as well. To in-
vestigate the presence of specific ligands and receptors in
the early urogenital ridge, RT-PCR was performed on RNA
isolated from E14 testis (Fig. 2). PCR for a constitutively
expressed gene cyclophilin was done to confirm the integ-
rity of the RNA for each sample (data not shown). PCR
for SRY was done to confirm the male genotype of the
gonad analyzed (data not shown). A brain RNA sample was
used as a positive control, and all the neurotropins and re-
ceptors were detected with the RT-PCR analysis (data not
shown). The RT-PCR was done on the same RNA sample,
and the experiment was repeated three times with three dif-
ferent RNA samples. The identity of the individual PCR
products were confirmed with a restriction digest and se-
quence analysis (data not shown). Of the three known high
affinity receptors, trkC and trkA were both present while
trkB was not. The neurotropin ligands NGF, NT3, BDNF,
and NT4/5 all yielded detectable PCR products, although
NT3 gave the strongest signal (Fig. 2). Therefore, the genes
for the neurotropins and receptors are expressed in the E14
embryonic testis.
To complement the RT-PCR analysis, an immunocyto-
chemical procedure was used to investigate the cellular lo-
calization of NT3 and trkC in the embryonic rat testis (Fig.
3). NT3 was primarily localized within the Sertoli cells at
E14. Interestingly, the trkC was primarily localized to in-
dividual cells of the interstitium at E16 and to the basal
surface of the cords in the peritubular cell region at E18
(Fig. 3). These data confirm the expression of the NT3 and
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FIG. 3. Immunohistochemistry for A)
NT3 at E14 (3400), B) NT3 at E14
(31000), C) trkC at E16 (31000), D) trkC
at E18 (3600) no counterstain, and E) trkC
at E18 (3600) counterstained with hemo-
toxylin to show morphology (published at
68%). Staining for NT3 is red and trkC is
brown. C, Cords; I, interstitium; P, peritu-
bular cells. Representative of at least three
experiments.
FIG. 4. Effects of trk inhibitor K252a on
organ cultures of E13 testis 1 mesoneph-
ros in culture for three days. Images of
whole organs treated with A) control sol-
vent DMSO or B) K252a (100 nM, repre-
sentative of three experiments with ap-
proximately six organ testis culture pairs
per experiment; one testis serves as a con-
trol, the other is treated). JB4 sections of
organ cultures were stained with toluidine
blue for C) control solvent DMSO or D)
K252a (100 nM). Testis (T) and mesoneph-
ros (M) are labeled. C,D) Representative
cords are marked by arrows.
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FIG. 5. Effects of trkC-IgG chimera on or-
gan cultures of E13 testis 1 mesonephros
in culture for three days. A) Control, B)
trkC-IgG (7.5 mg/ml). Testis (T) and meso-
nephros (M) are labeled. Representative of
four experiments with approximately six
organ culture pairs per experiment.
p75LNGFR expression in E13 organ cul-
tures treated with TrkC-IgG (7.5 mg/ml).
Dark gray stain denotes p75LNGFR ex-
pression in organ cultures. In 60% of or-
gan cultures, cord formation occurred (C),
while in 40% of organ cultures no cord
(D) formation occurred. P75LNGFR does
not stain cords and therefore is a good
marker to detect cord formation. M, Meso-
nephros; T, testis; C, cord. Dashed lines
separate testis from mesonephros.
trkC proteins. The localization suggests a potential inter-
action between NT3 produced in the cords with the peri-
tubular/adjacent mesenchymal surrounding the cords. As
previously discussed [20,21], the peritubular/adjacent mes-
enchyme to the cords appears to be derived in part from
the migrating mesonephros cells.
Perturbation of Neurotropin Action in Rat Testis Organ
Cultures
The presence of neurotropin ligands and receptors in the
rat embryonic testis, as well as the sex-specific expression
of p75/LNGFR just at the time of cord formation, suggest
that the neurotropins may be functioning in the morpho-
genesis of the early testis. To test this hypothesis, neurotro-
pin signaling was inhibited with the trk kinase inhibitor
K252a in embryonic testis organ cultures. K252a has been
shown to be specific for the trk receptors over that of any
other receptor-linked tyrosine kinases tested. However, at
high concentrations it can inhibit serine-threonine kinases
such as protein kinase C (PKC) [54–56]. Organ cultures of
the testis and the mesonephros were established at E13 be-
fore the development of cords. Over three days in culture,
cords formed in control organs. However, in cultures treated
with 100 nM K252a, cord formation was completely inhib-
ited (Fig. 4, B and D). Organ cultures of E13 testis and
mesonephros were also treated with a more specific highly
potent PKC inhibitor, calphostin C, as a control to ensure
that inhibition of PKC by K252a was not responsible for
these effects. Treatment with calphostin C did not inhibit
either cord formation or size of the embryonic testis (data
not shown). This implies that inhibition of PKC was not
responsible for the effects of K252a on the testis. Obser-
vations suggest that the inhibition of testis cords by K252a
is likely due to an inhibition of neurotropin actions.
Several more specific reagents were used in order to dis-
rupt signaling through neurotropins and the trk receptors.
Chimeric fusion proteins that contain a trk extracellular do-
main fused to human IgG have been developed that inhibit
receptor dimerization and bind to their corresponding li-
gand to block biological activity [57]. The chimeric pro-
teins used have cross-reactivity with human and rat tissues.
A trkC-IgG chimera was used to treat embryonic testis and
mesonephros organ cultures. Experiments were conducted
using 7.5 mg/ml (four experiments with approximately six
testis organ-culture pairs per experiment) and 50 mg/ml
(four experiments with approximately six testis organ-cul-
ture pairs per experiment) of trkC-IgG on E13 testis organ
cultures. Testis pairs were divided with one testis being
treated while the other served as the control. SRY PCR was
used to confirm the male genotype of the gonads (data not
shown). In 10 of 24 (i.e., approximately 40%) of testis or-
gan cultures treated with trkC-IgG, there was either inhi-
bition or dramatic reduction of cord formation (Fig. 5, A
and B). There did not appear to be a difference in cord
reduction between the doses of trkC-IgG used (data not
shown). Additionally, the trkC-IgG did not have an effect
on relative expression of p75LNGFR, but the staining with
p75LNGFR does demonstrate the reduction in cord struc-
tures present in the trkC-IgG chimera-treated testis organ
cultures (data not shown).
Experiments were conducted with a trkA-IgG chimera
(five experiments with approximately six testis organ-cul-
ture pairs per experiment) to determine what effect this fu-
sion protein receptor antagonist may have on cord forma-
tion in E13 treated testis organ cultures. TrkA-IgG did not
effect cord formation, but in 8 of 15 (53%) of the organ
cultures (Fig. 6), there was an increase in cord diameter or
swollen appearance in the cords. This swollen appearance
was determined to be an increase in size of some cells in
the cords and potential hypertrophy of the cells.
Experiments were conducted using a combination of
trkA-IgG and trkC-IgG (50 mg/ml; four experiments with
six testis organ-culture pairs per experiment) to determine
the effect on cord formation. In 12 of 24 (50%) of E13
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FIG. 6. Effects of trkA-IgG (50 mg/ml) on
of E13 testis organ cultures. H and E sec-
tions of control testis organ cultures A) at
380 or C) 31000 magnification (pub-
lished at 68%). Organ cultures treated
with trkA-IgG that had ‘‘swollen cord ef-
fect’’ at the same magnifications of A and
C, respectively. P75LNGFR staining is dark
grey. M, Mesonephros; T, testis; C, cords.
These are representatives of six experi-
ments with approximately 6 organ testis
pairs per experiment.
testis organ cultures treated, there appeared to be a reduc-
tion or absence of cords, and in approximately 20% there
were swollen cords (data not shown). This reduction is not
significantly different from trkC-IgG treatment alone. Treat-
ment of E13 testis organ cultures with trkB-IgG had no
effect on cord formation or cord morphology (data not
shown). This corresponds to the lack of trkB being detected
by PCR and provides a negative control protein for the trk-
IgG experiments.
To support the previous experiments, an additional ex-
periment was conducted with trkC antisense oligonucleo-
tide to determine what effect it might have on seminiferous
cord formation (data not shown). In fifty percent of organ
cultures treated (17 of 36 testis organ pairs) with a trkC
antisense oligonucleotide, seminiferous cord formation was
perturbed. Therefore, these experiments provide additional
support for a role for trkC in seminiferous cord formation.
Examination of NT3 and trkC Knockout Mouse Testis
Mice lacking NT3 have severe sensory and sympathetic
defects, and most die within 24 h of birth [58]. The testes
from NT3 knockout mice and their wild-type litter mates
were examined at E15 and E17. The testes from mice lack-
ing NT3 appear normal and contain histologically normal
cords (Fig. 7). Similar results were observed in a minimum
of 5 regions for each of 3 different sections (data not
shown). Interestingly, a reduced interstitium was observed
in the NT3 knockout mice (Fig. 7B), which remains to be
quantified.
Mice lacking trkC generally live until birth and die be-
tween Days 3 and 21 postnatally. They are completely de-
ficient in muscle afferents that innervate muscle spindles in
the periphery and project to the spinal cord. Thus, these
mice have difficulty in movement and localization of limbs
in space [59]. While the testes from trkC knockout mice
have normal formation of cords at E14 and P0, there ap-
pears to be less interstitium with the seminiferous cords in
closer apposition to each other (Fig. 8B). Staining with an
antibody for LNGFR demonstrated an increased population
of cells within the cords expressing p75/LNGFR in trkC
knockout mice when compared to heterozygous knockout
mice (Fig. 8B). This is an additional phenotype of the
knockout animals when compared to the heterozygous or
wild-type animals (Fig. 5). Therefore, the expression of dif-
ferent neurotropin receptors (e.g., LNGFR) may be altered
in the knockout animals.
DISCUSSION
The results presented suggest that neurotropins play a
role in the morphogenesis of the developing testis. This
adds to the growing body of evidence for nonneuronal ac-
tions of the neurotropins in development. Prior analysis of
the expression patterns of NGF and p75/LNGFR suggested
that neurotropins were potentially involved in many devel-
opmental processes at sites of mesenchymal-epithelial cell
interaction [44]. The identified sites of function so far as-
sociate with morphogenetic processes involving inductive
interactions leading to transitions from mesenchymal to ep-
ithelial cells (i.e., kidney and testis) or from epithelial to
mesenchymal cells (i.e., dermatome).
The appearance of p75/LNGFR in the testis correlated
with the morphogenetic event of cord formation. The sex
specificity and the timing of expression suggest that the
neurotropins may be involved in the early steps of male
sexual differentiation and particularly in the process of cord
formation. The parallels in the expression of p75/LNGFR
in the developing testis and ovary are instructive in thinking
about the potential roles of this receptor. p75/LNGFR is
present in the ovary mesenchyme surrounding the devel-
oping follicles in the late embryonic and early postnatal
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FIG. 7. NT3 knockout E15 testis. A) Wild-type, B) NT3 knockout. Rep-
resentative of three different animals.
FIG. 8. Immunohistochemistry for p75LNGFR in A) heterozygous con-
trols or B) homozygous trkC knockout mice in zero day testis. P75LNGFR
is dark brown. Sections are lightly counterstained with hemotoxylin.
3200 (published at 91%). Representative of four different animals for
each group.
period [39]. In the current experiments we have found that
expression is undetectable in the earlier ovary, which re-
mains unstructured during the time of cord formation in the
testis. p75/LNGFR protein is first detectable at E16 and
increases through E19 in the ovary just before the morpho-
logical rearrangements leading to follicle formation. Its ex-
pression in both male and female gonads specifically at the
time of the initial formation of testis cords and ovarian
follicle structures suggests that it may be performing a crit-
ical and analogous role in these processes. The presence of
trkC in the cells surrounding the cords (presumed to be the
peritubular cells) in E18 rat testis also supports the theory
that NT3 and trkC are important during the process of mor-
phological cord formation.
Treatment of embryonic testis in organ culture with the
tyrosine kinase inhibitor K252a resulted in complete inhi-
bition of cord formation. K252a is widely used as a trk-
specific inhibitor since other tyrosine kinases that have been
examined are not affected by K252a. K252a was found to
have no effect on the responses of the epidermal growth
factor receptor, platelet-derived growth factor receptor, fi-
broblast growth factor receptors, or src [46,48]. However,
several serine/threonine kinases can be inhibited by high
concentrations of K252a. The most obvious candidate is
protein kinase C (PKC), which is known to be a target of
K252a at high concentrations. However, PKC inhibition by
calphostin C did not interfere with cord formation, sug-
gesting that the effects of K252a were not mediated through
inhibition of PKC. The inhibition of cord formation by
K252a suggests that a trk receptor and neurotropin signal-
ing may be involved in testis cord formation.
Perturbing neurotropin function using more specific re-
agents used trk-IgG fusion proteins that inhibit the specific
trk receptors [57]. Treatment with the inhibitory trkC-IgG
antagonist resulted in inhibition of cord formation in 40%
of E13 testis organ cultures treated. The ability of trkC-IgG
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to prevent cord formation in testis organ cultures suggests
a role for trkC in testis cord formation. The variability of
the trkC-IgG response is not considered to be due to dose,
since the same response in cord reduction was achieved
using either 7.5 or 50 mg/ml. In addition, experiments with
antisense oligos to trkC had similar results as the trkC-IgG
fusion proteins. Several possibilities exist that may explain
the variability of these experiments. Three isoforms for the
trkC receptor exist with one being a nonfunctional receptor
and two containing different portions of the intracellular c-
terminus. There is no known function for these trkC iso-
forms, and the trkC-IgG chimeric protein used in these ex-
periments may be titering out a form of the receptor that is
inactive in the cell as a signaling molecule. NT3 may also
act at trkA or trkB with less efficiency to elicit its effect
[60]. There is also a possibility that a crucial window of
time exists in the development of testis where cord for-
mation can be perturbed, and this time could have been
partially missed in these experiments. Alternatively, since
the process of cord formation is the first morphological
event in the process of sex determination, this may be ac-
complished by more than one factor. There may be several
factors that act in a compensatory manner to orchestrate the
process of cord formation.
Both trkA and trkC receptors are expressed in the em-
bryonic testis, as well as minimally three ligands NGF,
NT3, and NT4/5. Treatment of E13 organ cultures with
trkA-IgG had no effect on cord formation but did influence
cord morphology. Therefore, trkA may effect embryonic
testis development, but not cord formation. A combination
of trkA-IgG and trkC-IgG did not significantly inhibit fur-
ther the reduction of cord formation compared to that of
trkC-IgG treatment alone. This suggests that trkC and not
trkA appears to be the important neurotropin receptor for
cord formation. The absence of detectable trkB by RT-PCR
suggests that BDNF and NT4/5 are unlikely to function
during embryonic testis development (at least not through
trkB). Treatment with trkB-IgG did not have an effect on
cord formation in testis organ cultures. Therefore, the trkB-
IgG protein can be considered a negative control for the
IgG chimera protein experiments.
The morphology of the NT3 and trkC knockout mice
was examined to determine if cord formation and testis
morphology were effected. In the current study, examina-
tion of the mice lacking NT3 revealed apparently normal
testis. Slight reductions in interstitial volume were observed
and require further investigation. If NT3 is involved in cord
formation, the knockout phenotype suggests that other fac-
tors are capable of compensating for its absence. While the
neurotropin knockouts have dramatic phenotypes, there are
many tissues in which there do not appear to be abnor-
malities. This is despite extensive evidence for specific neu-
rotropin function from expression and in vitro studies
([36,37] and [60–63]). This literature supports the idea that
a lack of phenotype in the knockout does not rule out a
role for the factor in a developmental process. In several
instances, the phenotypes of the trk receptor knockouts
were more dramatic than that of the cognate ligands
[58,59,61–64]. This suggests that other ligands may com-
pensate for the absence of one, which is reasonable given
the ability of multiple ligands to interact with a single re-
ceptor.
Knockout mice lacking trkC were also obtained and the
testis morphology examined. After observing several testes
from these knockouts, a reduction in area of the interstitium
was observed. Immunohistochemistry was conducted on
sections of trkC knockout mice testis, NT3 knockout testis,
and heterozygous controls for expression of p75LNGFR.
NT3 knockout mice had a similar pattern of expression of
p75LNGFR to controls; however, there appeared to be an
increase in the number of stained cells within the cords that
expressed p75LNGFR in the trkC knockout mice testis. In
controls and NT3 knockout mice, p75LNGFR stained in-
tensely around the cords in the interstitium. However, in
the trkC knockout mice there was low level of expression
throughout the testis including inside of the cords surround-
ing germ cells. The significance of this staining pattern re-
mains to be elucidated. The reduction in p75LNGFR pos-
itive cells in the interstitium in trkC knockouts may involve
reduced migration of cells from the mesonephros that even-
tually become part of the interstitium. p75LNGFR knock-
out mice do not appear to have as dramatic a phenotype as
NT3, trkC, or trkA knockout mice [65].
There are several possible roles for neurotropins at dif-
ferent steps in the processes leading to cord formation. One
possible function is stimulation of the initial migration of
peritubular cells from the mesonephros into the testis. This
would be consistent with the known abilities of neurotro-
pins in other systems. NGF has been widely studied as a
factor responsible for guiding the migration of neurons and
is capable of inducing neuronal morphogenesis [66]. NGF
also functions as a chemoattractant for melanocytes in the
skin and promotes migration by Schwann cells [67,45].
Therefore, neurotropins could be involved in the migration
of pre-peritubular cells into the testis. The expression of
p75/LNGFR on cells in the mesonephros before the ap-
pearance of any p75/LNGFR positive cells in the testis is
consistent with this idea. The expression of p75/LNGFR in
the mesonephros is particularly pronounced in the region
adjacent to the testis, suggesting that those cells may either
migrate into the testis or be involved in signalling inter-
actions with the testis. The immunohistochemical analysis
of NT3 and trkC in embryonic testis also support this hy-
pothesis. NT3 was localized within the Sertoli cells while
trkC was present in the layer of cells adjacent to the cords
(i.e., pre-peritubular cells). Previously the mesonephros
cells that migrate into the testis have been shown to derive
in part the peritubular layer of cells surrounding the cords
[20]. Therefore, the possibility exists that the NT3 produced
in the cords (i.e., Sertoli-germ cell aggregates) promote the
migration of mesonephros cells into the testis to become
peritubular cells and help promote cord formation. Another
possible role for neurotropins in the testis is in the inductive
interactions leading to cord formation by Sertoli cells. Neu-
rotropins might stimulate Sertoli cells to undergo a transi-
tion from mesenchyme to epithelia, which promotes aggre-
gation and cord formation. There is evidence for neurotro-
pin function in morphogenetic inductions in other systems.
The best functional data on NT3 outside of the nervous
system is in the process of dermis formation from the der-
matome, involving an epithelial to mesenchymal transition
[38].
The complex process of seminiferous cord formation is
the result of expression and activation of a series of genes
that initiate and maintain Sertoli cell differentiation. Ini-
tially, SRY is proposed to trigger the process of Sertoli cell
differentiation. In addition, SOX9 has been determined to
assist in sex determination and may potentially be regulated
or work cooperatively with SRY. Downstream of SRY and
SOX9, expression other genes such as TGFb2 and MIS
have been detected in Sertoli cells prior to seminiferous
cord formation. Their potential role appears to be in main-
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tenance of Sertoli cell differentiation and the creation of an
adequate environment to favor testis differentiation. The
current results lead to the intriguing possibility that neu-
rotropins may be involved in the process of cord formation
by Sertoli cells. The speculation is made that one of the
earliest steps in mammalian male sex determination after
SRY and SOX9 expression may be the production of neu-
rotropins and their receptors in the testis. Understanding
more about this process will provide insight into similar
morphogenetic processes in other developing organs. In ad-
dition, this data adds to the evidence for crucial nonneu-
ronal functions of the neurotropins in development.
ACKNOWLEDGMENTS
We thank Linda Miyashiro and Urvashi Patel for technical assistance.
We thank Lou Reichardt (UCSF San Francisco, CA) and Lino Tessarollo
(NCI, Rockville, MD) for providing knockout animals. We thank Klaus
Giese for the SRY primer sequences. We thank Jeff Parrott, Jaideep
Chaudhary, and Anne Donjacour for helpful discussions, and Julia Barfield
and Susan Cobb for assistance in preparation of the manuscript.
REFERENCES
1. Lovell-Badge R, Hacker A. The molecular genetics of SRY and its
role in mammalian sex determination. Philos Trans R Soc Lond B
Biol Sci 1995; 305:205–214.
2. Morais da Silva S, Hacker A, Harley V, Goodfellow P, Swain A,
Lovell-Badge R. SOX9 expression during gonadal development im-
plies a conserved role for the gene in testis differentiation in mammals
and birds. Nat Genet 1996; 14:62–67.
3. Van Dissel Emiliani FM, De Boer Brower M, De Rooij DG. Effect
of fibroblast growth factor-2 on Sertoli cells and gonocytes in co-
culture during the perinatal period. Endocrinology 1996; 137:647–
654.
4. Olaso R, Gaytier C, Levacher C, Durand P, Saez J, Habert R. The
immunohistochemical localization of transforming growth factor-beta
2 in the fetal and neonatal rat testis. Mol Cell Endocrinol 1997; 126:
165–172.
5. Jost A, Magre S, Agelopoulou R. Early stages of testicular differen-
tiation in the rat. Hum Genet 1981; 58:59–63.
6. Magre S, Jost A. The initial phases of testicular organogenesis in the
rat. An electron microscopy study. Arch Anat Microsc Morphol Exp
1980; 69:297–318.
7. Magre S, Jost A. Sertoli cells and testicular differentiation in the rat
fetus. J Electron Microsc Tech 1991; 19:172–188.
8. Karl J, Capel B. Three-dimensional structure of the developing mouse
genital ridge. Philos Trans R Soc Lond B Biol Sci 1995; 350:235–
242.
9. Pelletier RM, Byers SW. The blood-testis barrier and Sertoli cell junc-
tions: structural considerations. Microsc Res Tech 1992; 20:3–33.
10. Russell LD, Bartke A, Goh JC. Postnatal development of the Sertoli
cell barrier, tubular lumen, and cytoskeleton of Sertoli and myoid cells
in the rat, and their relationship to tubular fluid secretion and flow.
Am J Anat 1989; 184:179–189.
11. Russell LD, Tallon-Doran M, Weber JE, Wong V, Peterson RN. Three-
dimensional reconstruction of a rat stage V Sertoli cell: III. A study
of specific cellular relationships. Am J Anat 1983; 167:181–192.
12. Sertoli E. On the existence of special branched cells in the seminif-
erous tubules of the human testis. Morgagni 1965; 7:31–39.
13. Bressler RS, Ross MH. Differentiation of peritubular myoid cells of
the testis: effects of intratesticular implantation of newborn mouse
testes into normal and hypophysectomized adults. Biol Reprod 1972;
6:148–159.
14. Clermont Y. Contractile elements in the limiting membrane of the
seminiferous tubules of the rat. Exp Cell Res 1958; 15:438–440.
15. Ross MH. The fine structure and development of the peritubular con-
tractile cell component in the seminiferous tubules of the mouse. Am
J Anat 1967; 121:523–557.
16. Virtanen I, Kallajoki M, Narvanen O, Paranko J, Thornell LE, Miet-
tinen M, Lehto VP. Peritubular myoid cells of human and rat testis
are smooth muscle cells that contain desmin-type intermediate fila-
ments. Anat Rec 1986; 215:10–20.
17. George FW, Catt KJ, Neaves WB, Wilson JD. Studies on the regu-
lation of testosterone synthesis in the fetal rabbit testis. Endocrinology
1978; 102:665–673.
18. Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal
hormones. Recent Prog Horm Res 1953; 8:379–418.
19. Skinner MK. Cell-cell interactions in the testis. Endocr Rev 1991; 12:
45–77.
20. Buehr M, Gu S, McLaren A. Mesonephric contribution to testis dif-
ferentiation in the fetal mouse [published erratum appears in Devel-
opment 1993 Aug; 118(4): following 1384]. Development 1993; 117:
273–281.
21. Merchant-Larios H, Moreno-Mendoza N, Buehr M. The role of the
mesonephros in cell differentiation and morphogenesis of the mouse
fetal testis. Int J Dev Biol 1993; 37:407–415.
22. Moreno-Mendoza N, Herrera-Munoz J, Merchant-Larios H. Limb bud
mesenchyme permits seminiferous cord formation in the mouse fetal
testis but subsequent testosterone output is markedly affected by the
sex of the donor stromal tissue. Dev Biol 1995; 169:51–56.
23. Martineau J, Nordquist K, Tilmann C, Lovell-Badge R, Capel B. Male
specific cell migration into the developing gonad. Curr Biol 1997; 17:
958–968.
24. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell
Biol 1995; 7:148–155.
25. Barbacid M. Structural and functional properties of the TRK family
of neurotrophin receptors. Ann N Y Acad Sci 1995; 766:442–458.
26. Chao MV. The p75 neurotrophin receptor. J Neurobiol 1994; 25:1373–
1385.
27. Parada LF, Tsoulfas P, Tessarollo L, Blair J, Reid SW, Soppet D. The
Trk family of tyrosine kinases: receptors for NGF-related neurotro-
phins. Cold Spring Harbor Symp Quant Biol 1992; 57:43–51.
28. Tessarollo L, Tsoulfas P, Martin-Zanca D, Gilbert DJ, Jenkins NA,
Copeland NG, Parada LF. trkC, a receptor for neurotrophin-3, is wide-
ly expressed in the developing nervous system and in non-neuronal
tissues [published erratum appears in Development 1993 Aug; 118(4):
following 1384]. Development 1993; 118:463–475.
29. Heumann R. Neurotrophin signalling. Curr Opin Neurobiol 1994; 4:
668–679.
30. Weskamp G, Reichardt LF. Evidence that biological activity of NGF
is mediated through a novel subclass of high affinity receptors. Neuron
1991; 6:649–663.
31. Dobrowsky RT, Jenkins GM, Hannun YA. Neurotrophins induce
sphingomyelin hydrolysis. Modulation by co-expression of p75NTR
with Trk receptors. J Biol Chem 1995; 270:22135–22142.
32. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA.
Activation of the sphingomyelin cycle through the low-affinity neu-
rotrophin receptor. Science 1994; 265:1596–1599.
33. Davies AM. The role of neurotrophins in the developing nervous sys-
tem. J Neurobiol 1994; 25:1334–1348.
34. Davies AM, Wright EM. Neurotrophic factors. Neurotrophin autocrine
loops. Curr Biol 1995; 5:723–726.
35. Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, Karihaloo
M, Rullamas J, Evans T, McMahon SB, Armanini MP. Neurotropins
promote motor neuron survival and are present in embryonic limb
bud [see comments]. Nature 1993; 363:266–270.
36. Johnson J, Oppenheim R. Neurotrophins. Keeping track of changing
neurotrophic theory. Curr Biol 1994; 4:662–665.
37. Snider WD. Functions of the neurotropins during nervous system de-
velopment: what the knockouts are teaching us. Cell 1994; 77:627–
638.
38. Brill G, Kahane N, Carmeli C, von Schack D, Barde YA, Kalcheim
C. Epithelial-mesenchymal conversion of dermatome progenitors re-
quires neural tube-derived signals: characterization of the role of Neu-
rotrophin-3. Development 1995; 121:2583–2594.
39. Dissen GA, Hirshfield AN, Malamed S, Ojeda SR. Expression of neu-
rotrophins and their receptors in the mammalian ovary is develop-
mentally regulated: changes at the time of folliculogenesis. Endocri-
nology 1995; 136:4681–4692.
40. Mitsiadis TA, Luukko K. Neurotrophins in odontogenesis. Int J Dev
Biol 1995; 39:195–202.
41. Ojeda SR, Dissen GA, Junier MP. Neurotrophic factors and female
sexual development. Front Neuroendocrinol 1992; 13:120–162.
42. Sainio K, Saarma M, Nonclercq D, Paulin L, Sariola H. Antisense
inhibition of low-affinity nerve growth factor receptor in kidney cul-
tures: power and pitfalls. Cell Mol Neurobiol 1994; 14:439–457.
43. Sariola H, Saarma M, Sainio K, Arumae U, Palgi J, Vaahtokari A,
Thesleff I, Karavanov A. Dependence of kidney morphogenesis on
the expression of nerve growth factor receptor. Science 1991; 254:
571–573.
142 LEVINE ET AL.
44. Wheeler EF, Bothwell M. Spatiotemporal patterns of expression of
NGF and the low-affinity NGF receptor in rat embryos suggest func-
tional roles in tissue morphogenesis and myogenesis. J Neurosci 1992;
12:930–945.
45. Yaar M, Grossman K, Eller M, Gilchrest BA. Evidence for nerve
growth factor-mediated paracrine effects in human epidermis. J Cell
Biol 1991; 115:821–828.
46. Ayer-LeLievre C, Olson L, Ebendal T, Hallbook F, Persson H. Nerve
growth factor mRNA and protein in the testis and epididymis of
mouse and rat. Proc Natl Acad Sci USA 1988; 85:2628–2632.
47. Onoda M, Pflug B, Djakiew D. Germ cell mitogenic activity is as-
sociated with nerve growth factor-like protein(s). J Cell Physiol 1991;
149:536–543.
48. Persson H, Ayer-Le Lievre C, Soder O, Villar MJ, Metsis M, Olson
L, Ritzen M, Hokfelt T. Expression of beta-nerve growth factor re-
ceptor mRNA in Sertoli cells down regulated by testosterone. Science
1990; 247:704–707.
49. Lonnerberg P, Soder O, Parvinen M, Ritzen EM, Persson H. Beta-
nerve growth factor influences the expression of androgen-binding
protein messenger ribonucleic acid in the rat testis. Biol Reprod 1992;
47:381–388.
50. Russo MA, Odorisio T, Fradeani A, Rienzi L, De Felici M, Cattaneo
A, Siracusa G. Low-affinity nerve growth factor receptor is expressed
during testicular morphogenesis and in germ cells at specific stages
of spermatogenesis. Mol Reprod Dev 1994; 37:157–166.
51. Parrott J, Skinner MK. Thecal cell-granulosa cell interactions involve
a positive feedback loop among keratinocyte growth factor, hepatocyte
growth factor, and kit ligand during ovarian follicle development. En-
docrinology 1998; 139:2240–2245.
52. Itoh N, Patel U, Skinner MK. Developmental and hormonal regulation
of transforming growth factor-a and epidermal growth factor receptor
gene expression in isolated prostatic epithelial and stromal cells. En-
docrinology 1998; 139:1369–1377.
53. Itoh N, Patel U, Cupp AS, Skinner MK. Developmental and hormonal
regulation of transforming growth factor-b1 (TGFb1), -2, and -3 gene
expression in isolated prostatic epithelial and stromal cells: epidermal
growth factor and TGFb interactions. Endocrinology 1998; 139:1378–
1388.
54. Berg MM, Sternberg DW, Parada LF, Chao MV. K-252a inhibits nerve
growth factor-induced trk proto-oncogene tyrosine phosphorylation
and kinase activity. J Biol Chem 1992; 267:13–16.
55. Nye SH, Squinto SP, Glass DJ, Stitt TN, Hantzopoulos P, Macchi MJ,
Lindsay NS, Ip NY, Yancopoulos GD. K-252a and staurosporine se-
lectively block autophosphorylation of neurotrophin receptors and
neurotrophin-mediated responses. Mol Biol Cell 1992; 3:677–686.
56. Tapley P, Lamballe F, Barbacid M. K252a is a selective inhibitor of
the tyrosine protein kinase activity of the trk family of oncogenes and
neurotrophin receptors. Oncogene 1992; 7:371–381.
57. Shelton DL, Sutherland J, Gripp J, Camerator T, Armatini MP, Phillips
HS, Carroll K, Spencer SD, Levinson AD. Human trks: molecular
cloning, tissue distribution, and expression of extracellular domain
immunoadhesions. J Neurosci 1995; 15:477–491.
58. Farinas I, Jones KR, Backus C, Wang XY, Reichardt LF. Severe sen-
sory and sympathetic deficits in mice lacking neurotrophin-3. Nature
1994; 369:658–661.
59. Klein R, Silos-Santiago I, Smeyne RJ, Lira SA, Brambilla R, Bryant
S, Zhang L, Snider WD, Barbacid M. Disruption of the neurotrophin-3
receptor gene trkC eliminates muscle afferents and results in abnormal
movements [see comments]. Nature 1994; 368:249–251.
60. Ryden M, Ibanez CF. Binding of neurotrophin-3 to p75LNGFR, TrkA,
and TrkB mediated by a single functional epitope distinct from that
recognized by TrkC. J Biol Chem 1996; 271:5623–5627.
61. Ernfors P, Lee KF, Jaenisch R. Mice lacking brain-derived neurotroph-
ic factor develop with sensory deficits. Nature 1994; 368:147–150.
62. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads
to deficiencies in the peripheral nervous system and loss of limb pro-
prioceptive afferents. Cell 1994; 77:503–512.
63. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of
the BDNF gene perturbs brain and sensory neuron development but
not motor neuron development. Cell 1994; 76:989–999.
64. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL,
Barbacid M. Targeted disruption of the trkB neurotrophin receptor
gene results in nervous system lesions and neonatal death. Cell 1993;
75:113–122.
65. Lee KF, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV, Janisch
R. Targeted mutation of the gene encoding the low affinity NGF re-
ceptor p75 leads to defects in the peripheral sensory nervous system.
Cell 1992; 69:737–749.
66. Levi-Montalcini R. The nerve growth factor 35 years later. Science
1987; 237:1154–1162.
67. Anton ES, Weskamp G, Reichardt LF, Matthew WD. Nerve growth
factor and its low-affinity receptor promote Schwann cell migration.
Proc Natl Acad Sci USA 1994; 91:2795–2799.
